Literature DB >> 8527213

Role of vitamin K in bone metabolism.

C Vermeer1, K S Jie, M H Knapen.   

Abstract

Vitamin K is a cofactor required for the formation of gamma-carboxyglutamate (Gla) residues in proteins. Osteoblasts produce at least three different Gla-containing proteins: osteocalcin, matrix Gla-protein, and protein S. After cellular secretion of these proteins, the main part of each remains bound to the hydroxyapatite matrix in bone, but their function remains unclear. Part of the newly synthesized osteocalcin is also set free into the bloodstream, where it may be used as a diagnostic marker for bone formation. Several studies have demonstrated that a poor vitamin K status is associated with an increased risk of osteoporotic bone fractures. Whether vitamin K supplementation will reduce the rate of bone loss in postmenopausal women remains a matter of debate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527213     DOI: 10.1146/annurev.nu.15.070195.000245

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  25 in total

Review 1.  Vitamin K in cystic fibrosis.

Authors:  S P Conway
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

2.  Urinary levels of cross-linked N-terminal telopeptide of type I collagen and nutritional status in Japanese professional baseball players.

Authors:  Jun Iwamoto; Tsuyoshi Takeda; Kazuhiro Uenishi; Hiromi Ishida; Yoshihiro Sato; Hideo Matsumoto
Journal:  J Bone Miner Metab       Date:  2010-02-18       Impact factor: 2.626

3.  Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?

Authors:  E J Schoon; M C Müller; C Vermeer; L J Schurgers; R J Brummer; R W Stockbrügger
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  Effect of GGCX gene polymorphism on the responses of serum undercarboxylated osteocalcin and bone turnover markers after treatment with vitamin K2 (menatetrenone) among postmenopausal Thai women.

Authors:  Thawee Songpatanasilp; La-or Chailurkit; Suwannee Chantprasertyothin; Boonsong Ongphiphadhanakul; Nimit Taechakraichana
Journal:  J Bone Miner Metab       Date:  2011-02-23       Impact factor: 2.626

5.  Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted?

Authors:  O Gajic-Veljanoski; A M Bayoumi; G Tomlinson; K Khan; A M Cheung
Journal:  Osteoporos Int       Date:  2012-03-08       Impact factor: 4.507

6.  Effects of combined human parathyroid hormone (1-34) and menaquinone-4 treatment on the interface of hydroxyapatite-coated titanium implants in the femur of osteoporotic rats.

Authors:  Hang Li; Qiang Zhou; Bing-Li Bai; She-Ji Weng; Zong-Yi Wu; Zhong-Jie Xie; Zhen-Hua Feng; Liang Cheng; Viraj Boodhun; Lei Yang
Journal:  J Bone Miner Metab       Date:  2017-12-26       Impact factor: 2.626

7.  Effect of vitamin K2 and growth hormone on the long bones in hypophysectomized young rats: a bone histomorphometry study.

Authors:  Jun Iwamoto; Tsuyoshi Takeda; Yoshihiro Sato; James K Yeh
Journal:  J Bone Miner Metab       Date:  2007-01-01       Impact factor: 2.626

Review 8.  Efficacy of menatetrenone (vitamin K2) against non-vertebral and hip fractures in patients with neurological diseases: meta-analysis of three randomized, controlled trials.

Authors:  Jun Iwamoto; Hideo Matsumoto; Tsuyoshi Takeda
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 9.  From space to Earth: advances in human physiology from 20 years of bed rest studies (1986-2006).

Authors:  A Pavy-Le Traon; M Heer; M V Narici; J Rittweger; J Vernikos
Journal:  Eur J Appl Physiol       Date:  2007-07-28       Impact factor: 3.078

10.  Single-point assessment of warfarin use and risk of osteoporosis in elderly men.

Authors:  Claudine Woo; Linda L Chang; Susan K Ewing; Douglas C Bauer
Journal:  J Am Geriatr Soc       Date:  2008-06-10       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.